BRAF inhibitors (Nerviano)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBRAF inhibitors (Nerviano)
Drug Alias NameNMS-P383NMS-P186NMS-P349NMS-P396NMS-P285 +[6] 
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsAnticancer protein kinase inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNerviano Medical Sciences Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNerviano Medical Sciences Srl
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A